EI
ARNA

EAM Investors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

EAM Investors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-17,701
Closed -$1.32M – 430
2020
Q3 		$1.32M Sell
17,701
-11,270
-39% -$751K 0.31% 140
2020
Q2 		$1.82M Buy
+28,971
New +$1.59M 0.4% 106
2019
Q3 		– Sell
-25,356
Closed -$1.49M – 326
2019
Q2 		$1.49M Buy
+25,356
New +$1.31M 0.36% 127
2018
Q3 		– Sell
-16,509
Closed -$720K – 394
2018
Q2 		$720K Sell
16,509
-27,603
-63% -$1.19M 0.11% 253
2018
Q1 		$1.74M Sell
44,112
-64
-0.1% -$2.49K 0.29% 155
2017
Q4 		$1.5M Sell
44,176
-50,259
-53% -$1.43M 0.27% 167
2017
Q3 		$2.41M Buy
+94,435
New +$2.17M 0.32% 130

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

EAM Investors's ARNA Position: Q4 2020 in Review

EAM Investors sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2020, closing a stake of 17,701 shares — an estimated $1.32M sold.

EAM Investors first reported a position in ARNA in Q3 2017 and held it in 7 quarters. The position peaked at $2.41M in Q3 2017. 254 funds tracked by Wall St. Rank hold ARNA as of Q4 2020.

  • EAM Investors reported no remaining Arena Pharmaceuticals Inc position as of Q4 2020 after selling out during the quarter.
  • EAM Investors sold 17,701 Arena Pharmaceuticals Inc shares in Q4 2020, an estimated $1.32M.
  • EAM Investors first reported a position in Arena Pharmaceuticals Inc in Q3 2017 and held it in 7 quarters.
  • EAM Investors's Arena Pharmaceuticals Inc position peaked at $2.41M in Q3 2017.
  • 254 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2020.

Based on EAM Investors's 13F filing for Q4 2020, filed 11 Feb 2021.